TB: First new tuberculosis drug in fifty years risks being squandered without better research and pricing strategies
New TB drug bedaquiline illustrates need for paradigm shift in developing and ensuring access to new treatment combinations. Paris, October 30, 2013: Without a new approach to developing and pricing new tuberculosis medicines, the global TB response will be unable to deliver the new treatment combinations needed to close the deadly treatment gap for drug-resistant tuberculosis … Read more